Skip to the main content.
Login Contact us

1 min read

Arterys And Premier Partner For Special Pricing On AI Workflow Solutions

Arterys And Premier Partner For Special Pricing On AI Workflow Solutions

We are happy to announce that Arterys has been awarded a national group purchasing agreement for the Artificial Intelligence Solutions for Healthcare Category with Premier, Inc. The new agreement, effective from October this year, allows Premier members to take advantage of special pricing and terms pre-negotiated by Premier for Arterys' medical imaging platform and clinical AI workflow solutions.

 

AI-enhanced Workflows

Arterys offers radiology departments a dedicated medical imaging platform with a comprehensive set of clinical AI-enhanced workflow solutions - adding value across a wide range of specialties. The platform delivers fast, accurate, and actionable medical imaging insights that empower physicians to make more informed treatment decisions and deliver better patient care. With its industry-leading FDA-cleared medical imaging applications and AI, Arterys provides customers with a high return on investment and low implementation and management costs. 

Arterys CEO and Co-Founder, John Axerio-Cilies, says:

John Axerio-Cilies

"We are excited to offer Premier's members access to the Arterys Medical Imaging AI Platform. As many members struggle with staffing, the Arterys platform allows for a second look, workflow improvements, and reduced IT overhead."

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,400 U.S. hospitals and 250,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting, and other services, Premier enables better care and outcomes at a lower cost.

You can read our latest press release detailing our partnership with Premier HERE
 

Want to Learn MOre About Arterys?


Come meet with our team at RSNA 2022 at Booth #4719 later this month!

rsna 2022 arterys tempus-1


We're also putting on a tremendous session at RSNA, Tuesday, Nov 29, at 12:30 PM with our
Director of Product Management, Maya Khalifé. The presentation, Precision Oncology: Empowering Radiologists With AI-driven Workflow for Better Clinical Decisions in Cancer Patients, will answer many questions about Arterys' capabilities as a diagnostic platform that combines clinical AI and workflow optimization. Maya will also showcase Arterys' AI-based oncology platform and demonstrate how it provides comprehensive cancer patient reporting and follow-up through an innovative and efficient workflow.  

Don't forget to connect with us at Booth #4719 to discover first-hand Arterys' capabilities and how our software helps physicians provide better patient care.

Book a Demo at RSNA 2022

 

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys And Therapixel Team Up For AI-powered Breast Cancer Solution

Arterys, a Tempus company, has announced a US and EU distribution agreement with Therapixel, a medical imaging software company providing AI...

Read More
Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

Arterys' Breast AI Suite: Transforming Breast Screening & Cancer Detection at SBI 2023

The 2023 Society of Breast Imaging (SBI) Breast Imaging Symposium is a must-attend event for radiologists and healthcare professionals involved in...

Read More
March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

March Events: Procedural And Artificial Intelligence Developments In Oncology And Radiology

There are a lot of radiology conferences and events in March, and you can connect with the Arterys team at a number of them! Six specific events in...

Read More
Arterys has joined Tempus, and we are excited to reintroduce ourselves to you as Tempus Radiology.
Tempus is a leading technology company that is advancing precision medicine through the practical application of data and artificial intelligence in healthcare. By joining forces, Arterys’ product will be integrated into Tempus’ solutions, enabling providers to access a comprehensive patient view (now inclusive of radiology scans) and researchers to leverage this new data modality to optimize the drug development process.